Angiotensin-II-dependent changes in alpha-1 adrenoceptor vascular expression in pregnant rats

Pharmacology

Volumn 84, Issue 6, 2009, Pages 367-376

  López Sánchez, Pedro ^a   Bracho Valdés, Ismael ^b   Godínez Hernández, Daniel ^c   Bobadilla Lugo, Rosa A ^b  

^a Sección de Estudios de Posgrado e Investigación y   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

Author keywords

Adrenoceptors; Captopril; Hypertension; Preeclampsia; Pregnancy; Rat

Indexed keywords

8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ANGIOTENSIN II; CAPTOPRIL; PHENYLEPHRINE; PROPRANOLOL; RAUWOLSCINE;

ABDOMINAL AORTA; ALPHA ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; BLOOD PRESSURE REGULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HYPERTENSION; NONHUMAN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE CONTRACTILITY; THORACIC AORTA;

ADRENERGIC ALPHA-AGONISTS; ANGIOTENSIN II; ANIMALS; AORTA, ABDOMINAL; AORTA, THORACIC; BLOTTING, WESTERN; CAPTOPRIL; ENDOTHELIUM, VASCULAR; FEMALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PHENYLEPHRINE; PREGNANCY; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; VASCULAR RESISTANCE;

EID: 70449686639     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000258655     Document Type: Article

References (40)

1. Sibai BM, Frangieh A: Maternal adaptation to pregnancy. Curr Opin Obstet Gynecol 1995; 7: 420-426.
2. Duvekot JJ, Peeters LL: Renal hemodynamics and volume homeostasis in pregnancy. Obstet Gynecol Surv 1994; 49: 830-839.
3. Conrad KP, Vernier KA: Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol 1989; 257:R847-R853.
4. Cox BE, Rosenfeld CR, Kalinyak JE, Magness RR, Shaul PW: Tissue specific expression of vascular smooth muscle angiotensin II receptor subtypes during ovine pregnancy. Am J Physiol 1996; 271:H212-H221.
5. Cox BE, Word RA, Rosenfeld CR: Angiotensin II receptor characteristics and subtype expression in uterine arteries and myometrium during pregnancy. J Clin Endocrinol Metab 1996; 81: 49-58.
6. Bird IM, Millican DS, Magness RR: Specific pregnancy-induced angiotensin II type-1 receptor expression in ovine uterine artery does not involve formation of alternate splice variants or alternate promoter usage. Biol Reprod 1998; 59: 219-224.
7. Anguiano-Robledo L, Reyes-Melchor PA, Bobadilla-Lugo RA, Pérez-Alvarez VM, López-Sánchez P: Renal angiotensin-II receptors expression changes in a model of preeclampsia. Hypertens Pregnancy 2007; 26: 151-161.
8. Tsutsumi Y, et al: Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 1999; 104: 925-935.
9. Massicotte G, St-Louis J, Parent A, Schiffrin EL: Decreased in vitro responses to vasoconstrictor during pregnancy in normotensive and spontaneously hypertensive rats. Can J Physiol Pharmacol 1987; 65: 2466-2471. (Pubitemid 18085493)
10. Dogterom J, De Jong W: Diminished pressor responses to noradrenaline of the perfused tail arteries of pregnant rats. Eur J Pharmacol 1974; 25: 267-269.
11. Zuspan FP, Nelson GH, Ahlquist RP: Epinephrine infusions in normal and toxemic pregnancies. 1. Nonesterified fatty acids and cardiovascular alterations. Am J Obstet Gynecol 1964; 100: 218-221.
12. Paller MS: Mechanism of decreased pressor responsiveness to ANG II, NE and vasopressin in pregnant rats. Am J Physiol 1984; 247: H100-H108.
13. Piascik MT, Perez DM: Alpha1-adrenergic receptors: new insights and directions. J Pharmacol Exp Ther 2001; 298: 403-410.
14. Scofield MA, Liu F, Abel PW, Jeffries WB: Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. J Pharmacol Exp Ther 1995; 275: 1035-1042.
15. Tanoue A, Nasa Y, Koshimizu T, Shinoura H, Oshikawa S, Kawai T, Sunada S, Takeo S, Tsujimoto G: The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J Clin Invest 2002; 109: 765-775.
16. Zimmerman BG, Gomez J: Increased response to sympathetic stimulation in the cutaneous vasculature in the presence of angiotensin. Int J Neuropharmacol 1965; 4: 185-193.
17. Marano G, Argiolas L: Postjunctional regulation by angiotensin II of-1-adrenoceptormediated pressor responses in the rat. Eur J Pharmacol 1994; 261: 121-126.
18. Chen K, Zimmerman BG: Angiotensin IImediated renal vasoconstriction amenable to alpha 1-adrenoceptor blockade. Eur J Pharmacol 1995; 284: 281-288.
19. Grant TL, McGrath JC: Interactions between angiotensin II and alpha-adrenoceptor agonists mediating pressor responses in the pithed rat. Br J Pharmacol 1988; 95: 1229-1240.
20. Dowell FJ, Henrion D, Benessiano J, Poitevin P, Levy B: Chronic infusion of low-dose angiotensin II potentiates the adrenergic response in vivo. J Hypertens 1996; 14: 177-182.
21. van Kleef EM, Smits JF, De Mey JG, Cleutjens JP, Lombardi DM, Schwartz SM, Daemen MJ: Alpha 1-adrenoreceptor blockade reduces the angiotensin II-induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery. Circ Res 1992; 70: 1122-1127.
22. D'Angelo G, Osol G: Regional variation in resistance artery diameter responses to alpha-adrenergic stimulation during pregnancy. Am J Physiol 1993; 264:H78-H85.
23. Lamb VL, Schwartz AJ, Rohn WR, Kaiser L: Cyclooxygenase inhibitors depress norepinephrine constriction of rat abdominal, but not thoracic, aorta. Eur J Pharmacol 1994; 256: 221-226.
24. Asbún-Bojalil J, Castillo EF, Escalante BA, Castillo C: Does segmental difference in alpha 1-adrenoceptor subtype explain contractile difference in rat abdominal and thoracic aortae? Vascul Pharmacol 2002; 38: 169-175.
25. Godinez-Hernandez D, Gallardo-Ortíz IA, López- Sánchez P, Villalobos-Molina R: Captopril therapy decreases both expression and function of alpha-adrenoceptors in pre-hypertensive rat aorta. Auton Autacoid Pharmacol 2006; 26: 21-29.
26. Gisbert R, Noguera MA, Ivorra MD, D'Ocon P: Functional evidence of a constitutively active population of alpha(1D)-adrenoceptors in rat aorta. J Pharmacol Exp Ther 2000; 295: 810-817.
27. Forhead AJ, Broughton Pipkin F, Sutherland MF, Fowden AL: Changes in the maternal and fetal renin-angiotensin systems in response to angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation. Exp Physiol 1997; 82: 761-776.
28. Clements ML, Faber JE: Mechanical load opposes angiotensin-mediated decrease in vascular alpha 1-adrenoceptors. Hypertension 1997; 29: 1165-1172.
29. Li HT, Long CS, Gray MO, Rokosh DG, Honbo NY, Karliner JS: Cross talk between angiotensin AT1 and alpha 1-adrenergic receptors: angiotensin II downregulates alpha 1a-adrenergic receptor subtype mRNA and density in neonatal rat cardiac myocytes. Circ Res 1997; 81: 396-403.
30. Hu ZW, Shi XY, Okazaki M, Hoffman BB: Angiotensin II induces transcription and expression of alpha 1-adrenergic receptors in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 1995; 268: 1006-1014.
31. Villalobos-Molina R, Lopez-Guerrero JJ, Ibarra M: Alpha 1D-and alpha 1A-adrenoceptors mediate contraction in rat renal artery. Eur J Pharmacol 1997; 322: 225-227.
32. Deighan C, Methven L, Naghadeh MM, Wokoma A, Macmillan J, Daly CJ, Tanoue A, Tsujimoto G, McGrath JC: Insights into the functional roles of alpha(1)-adrenoceptor subtypes in mouse carotid arteries using knockout mice. Br J Pharmacol 2005; 144: 558-565.
33. Hague C, Lee SE, Chen Z, Prinster SC, Hall RA, Minneman KP: Heterodimers of alpha1B-and alpha1D-adrenergic receptors form a single functional entity. Mol Pharmacol 2006; 69: 45-55.
34. Kim TH, Weiner CP, Thompson LP: Effect of pregnancy on contraction and endotheliummediated relaxation of renal and mesenteric arteries. Am J Physiol 1994; 36:H41-H47.
35. Hu ZW, Kerb R, Shi XY, Wei-Lavery T, Hoffman BB: Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells. J Pharmacol Exp Ther 2002; 303: 563-573.
36. Dhein S, Giessler C, Becker K, Pönicke K, Brodde OE: Inositolphosphate formation in thoracic and abdominal rat aorta following Gq/11-coupled receptor stimulation. Naunyn Schmiedebergs Arch Pharmacol 2001; 363: 322-329.
37. Kenakin T: Pharmacologic Analysis of Drug-Receptor Interaction, ed 3. Philadelphia, Lippincott-Raven, 1997, pp 289-330.
38. Stephenson RP: A modification of receptor theory. Br J Pharmacol Chemother 1956; 11: 379-393.
39. Koshimizu TA, Yamauchi J, Hirasawa A, Tanoue A, Tsujimoto G: Recent progress in alpha 1-adrenoceptor pharmacology. Biol Pharm Bull 2002; 25: 401-408.
40. Enna SJ, Ferkany JW, Kenakin T, Williams M, Porsolt RD, Sullivan JP: Isolated tissues; in Williams M, Enna SJ (eds): Current Protocols in Pharmacology. New York, Wiley, 1998, pp 401-413.15.